07:43PM 12/02/09
ARCA, FortuNet: Midday Volume Plays
Several stocks trading under $5 were moving on above-average volume during Monday's session.
01:25PM 11/23/09
Poniard Finds Cash to Keep Lights On: BioBuzz
Poniard faces a cash-crunch situation after a failed drug test last week.
12:59PM 11/23/09
Biotech Stock Mailbag: FDA Playbook
Smart drug and biotech companies keep the FDA abreast of their clinical trial program throughout the long drug-development process.
06:01AM 11/20/09
Poniard, Netlist: Early Volume Plays
Several stocks trading under $5 were poised to move on above-average volume during Wednesday's session.
08:57AM 11/18/09
Poniard Rebounds On Picoplatin Colon Cancer Data
Poniard recovers part of Monday losses on data for picoplatin in colon cancer, and safety info
01:57PM 11/17/09
Poniard Plunges On Failure Of Picoplatin Study
Poniard Pharma drops more than 70 percent after lung cancer drug fails in late stage trial
12:42PM 11/16/09
Poniard's CEO Pulls a Belichick: BioBuzz
Risky late-game call puts Poniard in a deep financial hole.
11:59AM 11/16/09
A Closer Look at Cardium's Wound-Healing Drug: BioBuzz
Is it the drug or the gel that worked best in a phase II study?
10:51AM 11/16/09
Cell Therapeutics Lavishes Free Stock on Execs: BioBuzz
'Retention' bonus awarded to CEO Jim Bianco, his management team and directors.
09:23AM 11/16/09
Poniard Cancer Drug Misses Goal In Lung Cancer
Poniard Pharma says picoplatin did not improve survival in late stage study; shares tumble
09:07AM 11/16/09
Poniard Cancer Drug Fails Pivotal Study: BioBuzz
Lung cancer drug picoplatin doesn't prolong survival in phase III study.
08:01AM 11/16/09
Director Jay Hoag Sells $9.3M Worth of Netflix
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:39AM 11/10/09
Biotech Stock Mailbag: Poniard Predictions
Readers chime in on Poniard Pharmaceuticals, Chelsea Therapeutics, AMAG, Cel-Sci and Dendreon.
07:00AM 11/06/09



Connect with TheStreet